3D bioprinting revolutionizes medicine

Treviso, February 11, 2025 – Biofabrication is transforming the medical field, opening up new possibilities in surgical planning and personalized treatments. A concrete example of this revolution comes from the 3D Innovation Lab at Humanitas, where researchers have successfully reproduced human organs affected by diseases, thanks to the integration of advanced technologies in clinical and research laboratories.
Among the key solutions driving this innovation is Electrospider, the biofabrication system developed by Bio3DPrinting. Already adopted by Humanitas, this technology is proving to be a benchmark in medical research and personalized medicine.
Bio3DPrinting continues to invest in cutting-edge solutions to support the biomedical sector, contributing to the advancement of surgery and biomedical technologies.
Learn more in the RaiNews feature.
Request an appointment, fill out the form:
Related posts

Medica 2025: Bio3DPrinting Brings Biofabrication to Düsseldorf
Bio3DPrinting, together with Bio3DModel, will be present as an exhibitor at the MEDICA 2025 fair, scheduled for November 17th to 20th at the Düsseldorf exhibition center.

ESB 2025, Bio3DPrinting Brings Biofabrication
Dal 7 all’11 settembre 2025, Bio3DPrinting parteciperà in qualità di espositore al prestigioso congresso internazionale ESB – European Society of Biomaterials, che si terrà presso il centro congressi del Lingotto di Torino.

Biofabrication 2025, Bio3DPrinting brings its technologies
From September 14 to 17, 2025, Bio3DPrinting will participate in Biofabrication 2025, one of the most anticipated international scientific events dedicated to emerging technologies for biofabrication and tissue engineering.